Voluntary and Business Update Announcement New Drug Application of Methylthioninium Chloride Enteric-coated Sustained-release Tablets Accepted in China
2023-02-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
2023-02-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
2023-01-03
Voluntary and Business Update Announcement Gaining Exclusive License for Ruxolitinib Cream for the Treatment of Vitiligo and Atopic Dermatitis
2022-12-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
2022-12-01
Next Day Disclosure Return
2022-11-24
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
2022-11-01
Next Day Disclosure Return
2022-10-12
Voluntary and Business Update Announcement Gaining Exclusive License for BMI Botulinum Toxin Product
2022-10-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
2022-10-07